Matthew D’Ambrosio
Director/Board Member at BRIGHTSPRING HEALTH SERVICES, INC.
Net worth: 11 250 $ as of 2024-05-30
Profile
Matthew D’Ambrosio currently works at BrightSpring Health Services, Inc., as Independent Director from 2022.
Mr. D’Ambrosio also formerly worked at Sumitomo Pharma America, Inc., as Chief Compliance & Ethics Office from 2010 to 2017 and Reliant Pharmaceuticals LLC, as Chief Compliance Office.
Mr. D’Ambrosio received his Masters Business Admin degree from Rutgers State University of New Jersey, undergraduate degree from Rider University, and graduate degree from Seton Hall University School of Law.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-19 | 1,000 ( 0.00% ) | 11 250 $ | 2024-05-30 |
Matthew D’Ambrosio active positions
Companies | Position | Start |
---|---|---|
BRIGHTSPRING HEALTH SERVICES, INC. | Director/Board Member | 2022-09-30 |
Former positions of Matthew D’Ambrosio
Companies | Position | End |
---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Compliance Officer | 2017-10-31 |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Compliance Officer | - |
Training of Matthew D’Ambrosio
Rutgers State University of New Jersey | Masters Business Admin |
Rider University | Undergraduate Degree |
Seton Hall University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BRIGHTSPRING HEALTH SERVICES, INC. | Health Services |
Private companies | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
- Stock Market
- Insiders
- Matthew D’Ambrosio